Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Briggs

Showing results (101-110 of 229) with videos related to

Pageof 23
Sort By:
Advances in Therapy|August 19, 2016
A Systematic Review and Network Meta-Analysis to Evaluate the Comparative Efficacy of Interventions for Unfit Patients with Chronic Lymphocytic LeukemiaNicolas Städler, Aijing Shang, Francesc Bosch, et al.
Journal of Comparative Effectiveness Research|September 10, 2025
Composite endpoints in health technology assessment: Part 1 - an illustration of best modeling practiceAndrew Briggs, Aris Angelis, Jieling Chen, et al.
Pharmacoeconomics|February 3, 2018
A Decision-Analytic Model to Assess the Cost-Effectiveness of Etelcalcetide vs. CinacalcetBjörn Stollenwerk, Sergio Iannazzo, Ron Akehurst, et al.
Pharmacoeconomics|November 5, 2020
Budget Impact of Oral Semaglutide Intensification versus Sitagliptin among US Patients with Type 2 Diabetes Mellitus Uncontrolled with MetforminElizabeth Wehler, Dominik Lautsch, Stacey Kowal, et al.
Journal of Comparative Effectiveness Research|September 10, 2025
Composite endpoints in health technology assessment: Part 2 - expanding the evidence base with a framework for best modeling practiceAndrew Briggs, Jieling Chen, David Booth, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|January 23, 2010
Exploring the impact of changes in neurogenic urinary incontinence frequency and condition-specific quality of life on preference-based outcomesWilliam Hollingworth, Jonathan D Campbell, Jonathan Kowalski, et al.
Health Economics|March 1, 2005
Probabilistic sensitivity analysis for NICE technology assessment: not an optional extraKarl Claxton, Mark Sculpher, Chris McCabe, et al.
Pharmacoeconomics|October 8, 2021
Cost Effectiveness of Vericiguat for the Treatment of Chronic Heart Failure with Reduced Ejection Fraction Following a Worsening Heart Failure Event from a US Medicare PerspectiveAdnan Alsumali, Laurence M Djatche, Andrew Briggs, et al.
BMC Musculoskeletal Disorders|February 19, 2010
Effects of an exercise and manual therapy program on physical impairments, function and quality-of-life in people with osteoporotic vertebral fracture: a randomised, single-blind controlled pilot trialKim L Bennell, Bernadette Matthews, Alison Greig, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 8, 2016
Estimating Health-State Utility for Economic Models in Clinical Studies: An ISPOR Good Research Practices Task Force ReportSorrel E Wolowacz, Andrew Briggs, Vasily Belozeroff, et al.
Pageof 23

Showing results (101-110 of 229) with videos related to

Sort By:
Pageof 23
Advances in Therapy|August 19, 2016
A Systematic Review and Network Meta-Analysis to Evaluate the Comparative Efficacy of Interventions for Unfit Patients with Chronic Lymphocytic LeukemiaNicolas Städler, Aijing Shang, Francesc Bosch, et al.
Journal of Comparative Effectiveness Research|September 10, 2025
Composite endpoints in health technology assessment: Part 1 - an illustration of best modeling practiceAndrew Briggs, Aris Angelis, Jieling Chen, et al.
Pharmacoeconomics|February 3, 2018
A Decision-Analytic Model to Assess the Cost-Effectiveness of Etelcalcetide vs. CinacalcetBjörn Stollenwerk, Sergio Iannazzo, Ron Akehurst, et al.
Pharmacoeconomics|November 5, 2020
Budget Impact of Oral Semaglutide Intensification versus Sitagliptin among US Patients with Type 2 Diabetes Mellitus Uncontrolled with MetforminElizabeth Wehler, Dominik Lautsch, Stacey Kowal, et al.
Journal of Comparative Effectiveness Research|September 10, 2025
Composite endpoints in health technology assessment: Part 2 - expanding the evidence base with a framework for best modeling practiceAndrew Briggs, Jieling Chen, David Booth, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|January 23, 2010
Exploring the impact of changes in neurogenic urinary incontinence frequency and condition-specific quality of life on preference-based outcomesWilliam Hollingworth, Jonathan D Campbell, Jonathan Kowalski, et al.
Health Economics|March 1, 2005
Probabilistic sensitivity analysis for NICE technology assessment: not an optional extraKarl Claxton, Mark Sculpher, Chris McCabe, et al.
Pharmacoeconomics|October 8, 2021
Cost Effectiveness of Vericiguat for the Treatment of Chronic Heart Failure with Reduced Ejection Fraction Following a Worsening Heart Failure Event from a US Medicare PerspectiveAdnan Alsumali, Laurence M Djatche, Andrew Briggs, et al.
BMC Musculoskeletal Disorders|February 19, 2010
Effects of an exercise and manual therapy program on physical impairments, function and quality-of-life in people with osteoporotic vertebral fracture: a randomised, single-blind controlled pilot trialKim L Bennell, Bernadette Matthews, Alison Greig, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 8, 2016
Estimating Health-State Utility for Economic Models in Clinical Studies: An ISPOR Good Research Practices Task Force ReportSorrel E Wolowacz, Andrew Briggs, Vasily Belozeroff, et al.
Pageof 23